SPL-108 mitigates metastasis and chemoresistance in tubo-ovarian carcinoma
Olivia D. Lara(The University of Texas MD Anderson Cancer Center), Kari Hacker(NYU Langone Health)
Cited by 1
Related Papers
Therapeutic efficacy of liposomal Grb2 antisense oligodeoxynucleotide (L-Grb2) in preclinical models of ovarian and uterine cancer
|Oncotarget|2020|10
Evaluating the therapeutic efficacy of Grb2 inhibition in ovarian malignancies
|Digital Commons-TMC (Texas Medical Center)|2019|0